Hypera-Sanofi deal unconditionally cleared in Brazil
MLex Summary: Hypera's planned buyout of 12 medicine brands from Sanofi Medley Farmacêutica has been cleared, without conditions, by the Brazilian competition authority, according to a statement. The parties filed paperwork with...To view the full article, register now.
Already a subscriber? Click here to view full article